… occurs with high doses of inhaled corticosteroid above 1.5 mg/… Inhaled corticosteroids in
doses above 1.5 mg/d (0.75 mg/d … by postmenopausal estrogen replacement therapy. Although …

… to number of canisters of inhaled corticosteroid used the year before the index case. In total,
93% of prescribed canisters of inhaled corticosteroid contained beclomethasone, 200 puffs …

… long-term effects of inhaled corticosteroid monotherapy in mild asthma. … Short-term studies
of inhaled corticosteroids for COPD have … The use of inhaled corticosteroids was tapered and …

Inhaled corticosteroids (ICS) are the most effective controllers of … -line therapy for all patients
with persistent asthma, controlling asthma symptoms and preventing exacerbations. Inhaled …

… Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist
therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, …

… Budesonide and FP have been important advances in inhaled corticosteroid therapy. They
have reduced systemic effects because of greater first-pass hepatic metabolism than BDP. …

… a large body of evidence that inhaled corticosteroid therapy produces clinical benefits for
patients with asthma. In our study, users of inhaled corticosteroids had 45% fewer subsequent …

… inhaled corticosteroids as first-line therapy for patients with asthma.1, 6 Regular use of low-dose
inhaled corticosteroids … directly correlated to the amount of inhaled corticosteroid used. …

… Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of
inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. …

… Inhaled corticosteroids (ICSs) are the most effective anti-inflammatory agents available for
the treatment of asthma and represent the mainstay of therapy … of glucocorticoid therapy that …